About Peter Finn
Peter Finn is a secretary at Zetagen Therapeutics.
Peter Finn first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Finn in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Peter Finn works with at each company, as listed on that company's latest Form D.
Zetagen Therapeutics, Inc. · Form D/A, Nov 12, 2025
JL
Joe Loy
Executive officer and director
RW
Richard Warburg
Director
AK
Ashok Kaveeshwar
Director
NM
Nikhil Thakur, MD
Executive officer and director
DB
Donald Brown
Director